ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1093

Female Sexual Function in Fibromyalgia

Maria Julieta Gamba1, Claudia Uña1, Alicia Igel1, Fernando Eraña1, Maritza Vidal1, Gimena Gómez2, Griselda Redondo1, Maria Celina de la Vega1, Estella Chiuzzi1, Augusto Martin Riopedre Sr.1, Maria Ines de la Barrera3, Norma Villa1, Dario Mata1, Alba Russo1 and Osvaldo Daniel Messina1, 1REUMATOLOGIA, HOSPITAL ARGERICH, BUENOS AIRES, Argentina, 2Hospital Argerich, Buenos Aires, Argentina, 3HOSPITAL ARGERICH, HOSPITAL ARGERICH, BUENOS AIRES, Argentina

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Sexuality and fibromyalgia

  • Tweet
  • Email
  • Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes: Clinical Focus

Session Type: Abstract Submissions (ACR)

Background/Purpose: Fibromyalgia (FM) is a common condition in young and middle-aged women, which is mainly characterized by diffuse chronic pain and is associated with other manifestations such as fatigue, unrefreshing sleep, stiffness, anxiety and depresión1. Recent studies have evaluated that chronic pain syndrome and related manifestations could have a negative impact on sexual function of these patients, as well as psycho-physical abuse history could act as potential triggers of FM. OBJECTIVE: Assess sexual function in women with FM and correlate with tender points count, clinical severity, anxiety, depression, chronic fatigue and history of physical and psychological violence.

Methods: A case-control study. Between 03/01/12 and 06/30/12 were included consecutively: women >18 years diagnosed with FM according to ACR criteria ’90, and healthy controls >18 years, without history of violence. We excluded patients with other causes of chronic pain disorders and psychotic disorders. We recorded: sociodemographic data, education, employment and menopausal status and sexual function by Female Sexual Function Index2 (FSFI: self-administered questionnaire that assesses six domains). In the FM group tender points count, duration of disease, medication, psychological care, presence of chronic fatigue (by Fukuda Criteria), clinical severity (FIQ-Spanish version ), depression (HADS), and history of physical or psychological violence (Screening Questionnaire of Violence)3  were assessed. We used Chi2test, Student t test and Mann-Whitney test, and Spearman correlation coefficient (significant p ≤ 0.05).

Results:  We included 52 patients in the FM group and 52 in the control group. Median age: 50 ± 9.2 and 47 ± 10 years, respectively. FM Group: Medium evolution time: 60 months, mean pain points: 15 ± 3, FIQ median: 67.8 (28-86). 73.1% received medication for FM and 44.2% demanded psychological care. Patients with FM showed variables

Conclusion: Our patients with FM had impaired sexual function compared to control group. Physical and psychological violence were frequent but weren´t related with sexuality function.

1. Kalichman L. Association Between Sexual Dysfunction and FM. Clinical Rheum 2009, 28: 365-69.

2.Blumel JE, Binfa LE, Cataldo PA, Carrasco AV. Female Sexual Function Index: a test to assess women’s sexuality. Rev Chil. Obstetrics Gynecol 2004; 69 (2): 118-125.
3. Tavara-Orozco L, Zegarra-Samame Turra, Ceiso Zelaya.
Screening Gender Violence: three services reproductive health care. Ginecol. Obstet (Peru) 2003, 49 (1): 31-


Disclosure:

M. J. Gamba,
None;

C. Uña,
None;

A. Igel,
None;

F. Eraña,
None;

M. Vidal,
None;

G. Gómez,
None;

G. Redondo,
None;

M. C. de la Vega,
None;

E. Chiuzzi,
None;

A. M. Riopedre Sr.,
None;

M. I. de la Barrera,
None;

N. Villa,
None;

D. Mata,
None;

A. Russo,
None;

O. D. Messina,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/female-sexual-function-in-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology